Anika Therapeutics | ANIK - Costo Del Venduto





Costo Del Venduto Cambiamento Data
Abbott USD 5.3B 380M 2026-03
Agenus USD 642K 399K 2025-09
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Anika Therapeutics USD 11.44M 797K 2025-12
Halozyme Therapeutics USD 108.75M 6.6M 2026-03
Heron Therapeutics USD 11.12M 795K 2025-12
Insmed USD 49.5M 3.34M 2026-03
Integra LifeSciences USD 178.71M 14.73M 2026-03
Intrexon USD 1.01M 344K 2024-06
J&J USD 8.07B 103M 2026-03
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Ligand Pharmaceuticals USD 11.37M 8.38M 2026-03
MacroGenics USD 9.53M 585K 2026-03
Merit Medical Systems USD 197.08M 1.5M 2026-03
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12
Stryker USD 2.36B 325M 2026-03
Veracyte USD 38.49M 794K 2026-03
Xencor USD 61.66M 50.95M 2025-06
Zimmer Biomet Holdings USD 738.3M 231.8M 2026-03